Efficacy of Peppermint Oil in Irritable Bowel Syndrome

S. Dehury, H. Das, Abhipsa Patra, Rashmita Pradhan
{"title":"Efficacy of Peppermint Oil in Irritable Bowel Syndrome","authors":"S. Dehury, H. Das, Abhipsa Patra, Rashmita Pradhan","doi":"10.46347/jmsh.v8i1.21.7","DOIUrl":null,"url":null,"abstract":"Irritable Bowel Syndrome (IBS) is a functional bowel disorder characterized by abdominal pain or discomfort and altered bowel habits in absence of detectable structural abnormalities with worldwide incidence of 10-20%. According to Rome IV criteria subtypes of IBS can be IBS-D, IBS-C and IBS-M. Both non pharmacological and pharmacological therapy are available for IBS. Earlier Peppermint Oil (PO) was used in different types of abdominal pain. An oral formulation of PO is used in patients of IBS to improve symptoms. Hence the study was conducted to assess the efficacy of Peppermint Oil in IBS patients.METHOD: A prospective randomized, placebo-controlled study of 6month was done in Dept. of Pharmacology and Gastroenterology, SCBMCH, Cuttack. A total of 60 IBS patients(18-60yr) were included in the study. They were divided randomly into two groups by lottery system. Gr-1 received PO 180mg TDS 60 min before breakfast, lunch, dinner and Gr-2 received placebo. The baseline and follow-up parameters of Total IBS symptom Score (TISS) were recorded at 0hr, 24hr and 4wks of treatment in both groups and Pain was assessed using Numeric Rating Scale. Statistical analysis were done using Mann-Whitney Test and Wilcoxon signed ranked Test. RESULTS: There was significant reduction in TISS and PAIN score at 24hr and 4weeks with Peppermint Oil from the baseline with Placebo.CONCLUSION : Peppermint oil was found to be effective in IBS patients. Keywords: Irritable Bowel Syndrome, Peppermint Oil, Total IBS symptom score, Numeric Pain rating scale","PeriodicalId":33653,"journal":{"name":"Journal of Medical Sciences and Health","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Sciences and Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46347/jmsh.v8i1.21.7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Irritable Bowel Syndrome (IBS) is a functional bowel disorder characterized by abdominal pain or discomfort and altered bowel habits in absence of detectable structural abnormalities with worldwide incidence of 10-20%. According to Rome IV criteria subtypes of IBS can be IBS-D, IBS-C and IBS-M. Both non pharmacological and pharmacological therapy are available for IBS. Earlier Peppermint Oil (PO) was used in different types of abdominal pain. An oral formulation of PO is used in patients of IBS to improve symptoms. Hence the study was conducted to assess the efficacy of Peppermint Oil in IBS patients.METHOD: A prospective randomized, placebo-controlled study of 6month was done in Dept. of Pharmacology and Gastroenterology, SCBMCH, Cuttack. A total of 60 IBS patients(18-60yr) were included in the study. They were divided randomly into two groups by lottery system. Gr-1 received PO 180mg TDS 60 min before breakfast, lunch, dinner and Gr-2 received placebo. The baseline and follow-up parameters of Total IBS symptom Score (TISS) were recorded at 0hr, 24hr and 4wks of treatment in both groups and Pain was assessed using Numeric Rating Scale. Statistical analysis were done using Mann-Whitney Test and Wilcoxon signed ranked Test. RESULTS: There was significant reduction in TISS and PAIN score at 24hr and 4weeks with Peppermint Oil from the baseline with Placebo.CONCLUSION : Peppermint oil was found to be effective in IBS patients. Keywords: Irritable Bowel Syndrome, Peppermint Oil, Total IBS symptom score, Numeric Pain rating scale
薄荷油治疗肠易激综合征疗效观察
肠易激综合征(IBS)是一种功能性肠道疾病,其特征是在没有可检测到的结构异常的情况下出现腹痛或不适和排便习惯改变,全球发病率为10-20%。根据罗马IV标准,IBS的亚型可以是IBS-D、IBS-C和IBS-M。非药物治疗和药物治疗均可用于IBS。早期的薄荷油(PO)用于治疗不同类型的腹痛。口服PO制剂用于IBS患者以改善症状。因此,本研究旨在评估薄荷油对IBS患者的疗效。方法:一项为期6个月的前瞻性随机安慰剂对照研究在卡塔克SCBMCH药理学和胃肠道学系进行。共有60名IBS患者(18-60岁)被纳入研究。他们被抽签系统随机分为两组。Gr-1在早餐、午餐、晚餐前60分钟接受PO 180mg TDS,Gr-2接受安慰剂。两组在治疗0小时、24小时和4周时记录IBS症状总分(TISS)的基线和随访参数,并使用数字评定量表评估疼痛。使用Mann-Whitney检验和Wilcoxon签名排序检验进行统计分析。结果:与安慰剂相比,薄荷油在24小时和4周时可显著降低TISS和PAIN评分。结论:薄荷油对IBS患者有效。关键词:肠易激综合征,薄荷油,IBS症状总分,疼痛数值评定量表
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
17
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书